Adamo H P, Grimaldi M E
IQUIFIB-Facultad de Farmacia y Bioquímica (UBA), Junín 956, 1113 Capital Federal, Buenos Aires, Argentina.
Biochem J. 1998 May 1;331 ( Pt 3)(Pt 3):763-6. doi: 10.1042/bj3310763.
A mutant of the plasma membrane Ca2+ pump (PMCA) called (nCI)hPMCA4b(ct120), in which the C-terminal regulatory segment including the calmodulin-binding autoinhibitory domains C and I had been relocated near the N-terminus, has been expressed in COS-1 cells. The measurements of Ca2+ transport in microsomal preparations showed that the rearranged enzyme was functional. The activity of the (nCI)hPMCA4b(ct120) mutant was compared with those of the wild-type hPMCA4b and the fully active calmodulin-insensitive mutant hPMCA4b(ct120). In the absence of calmodulin the activity of (nCI)hPMCA4b(ct120) was higher than that of hPMCA4b but only 45% of that of hPMCA4b(ct120). Mutant (nCI)hPMCA4b(ct120) exhibited an apparent affinity for Ca2+ similar to that of hPMCA4b, typical of the inhibited state of the enzyme. Calmodulin at concentrations that fully activated hPMCA4b increased the activity of (nCI)hPMCA4b(ct120) to 68% of that of hPMCA4b(ct120). The lower maximal activity of (nCI)hPMCA4b(ct120) was not due to a lower affinity for calmodulin because the concentration of calmodulin required for half-maximal activation of (nCI)hPMCA4b(ct120) was equal to that of the wild-type hPMCA4b. These results indicate that (1) the disturbance of the N-terminal region of the PMCA by the insertion of the C-terminal segment decreased the ability of the pump to transport Ca2+, and (2) the calmodulin-binding autoinhibitory domain was still able to access its acceptor site from the N-terminal end of the molecule. However, although the calmodulin-binding and inhibitory functions of the C-domain were fully preserved, the I domain at its new position seemed less effective at inhibiting the pump.
一种名为(nCI)hPMCA4b(ct120)的质膜钙泵(PMCA)突变体已在COS-1细胞中表达,该突变体的C末端调节片段(包括钙调蛋白结合自抑制结构域C和I)已重新定位到N末端附近。微粒体制剂中钙转运的测量结果表明,重排后的酶具有功能。将(nCI)hPMCA4b(ct120)突变体的活性与野生型hPMCA4b和完全活性的钙调蛋白不敏感突变体hPMCA4b(ct120)的活性进行了比较。在没有钙调蛋白的情况下,(nCI)hPMCA4b(ct120)的活性高于hPMCA4b,但仅为hPMCA4b(ct120)的45%。突变体(nCI)hPMCA4b(ct120)对Ca2+的表观亲和力与hPMCA4b相似,这是该酶抑制状态的典型特征。能使hPMCA4b完全激活的钙调蛋白浓度可将(nCI)hPMCA4b(ct120)的活性提高到hPMCA4b(ct120)的68%。(nCI)hPMCA4b(ct120)较低的最大活性并非由于对钙调蛋白的亲和力较低,因为使(nCI)hPMCA4b(ct120)达到最大活性一半所需的钙调蛋白浓度与野生型hPMCA4b相同。这些结果表明:(1)通过插入C末端片段对PMCA的N末端区域造成的干扰降低了泵转运Ca2+的能力;(2)钙调蛋白结合自抑制结构域仍能够从分子的N末端接近其受体位点。然而,尽管C结构域的钙调蛋白结合和抑制功能完全保留,但处于新位置的I结构域在抑制泵方面似乎效果较差。